Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism

Oncogene
B GalyH Prats

Abstract

Fibroblast growth factor-2 (FGF-2) is a powerful mitogen and angiogenic factor whose expression is strongly regulated at the translational level. The constitutive upregulation of FGF-2 isoforms in transformed cells prompted us to investigate the post-transcriptional effects of a tumour suppressor, p53, on FGF-2 expression. We show here in human primary skin fibroblasts that the cell density-dependent variation of FGF-2 mRNA translatability was inversely correlated with endogenous p53 expression. Transient cell transfection revealed an inhibitory effect of wild-type p53 on the expression of chimeric FGF--CAT proteins. RNAse mapping experiments ruled out any effect of p53 on FGF--CAT mRNA accumulation, suggesting a translational inhibition. This inhibition was mediated by the FGF-2 mRNA leader, but not by vascular endothelial growth factor or platelet derived growth factor mRNA leaders. Neither p53-like protein p73, nor p21/waf had any inhibitory activity. Furthermore a set of hot spot mutants of p53 bearing mutations in the DNA binding domain had no post-transcriptional inhibitory effect. In contrast a p53 mutant of the transactivating domain was still able to block FGF--CAT expression, indicating that the post-transcriptional a...Continue Reading

References

Jul 5, 1991·Science·M HollsteinC C Harris
Mar 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H PratsJ A Smith
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R Z Florkiewicz, A Sommer
Nov 1, 1984·Somatic Cell and Molecular Genetics·J H SangD Ish-Horowicz
Sep 1, 1995·Genes & Development·Y HauptM Oren
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Mar 18, 1996·Biochimica Et Biophysica Acta·M E Ewen, S J Miller
May 16, 1996·Biochimica Et Biophysica Acta·N Bouck
Mar 1, 1996·The British Journal of Ophthalmology·J Pe'erE Keshet
Feb 1, 1997·Endocrine Reviews·A BikfalviD B Rifkin
Apr 4, 1997·The Journal of Biological Chemistry·J BernsteinO Elroy-Stein
Dec 24, 1997·Oncogene·E ShaulianM Oren
Jan 1, 1997·Folia Microbiologica·J DvorákováJ Kopecký
Feb 5, 1999·Biochimica Et Biophysica Acta·T NishimuraN Itoh

❮ Previous
Next ❯

Citations

May 3, 2007·Apoptosis : an International Journal on Programmed Cell Death·Sylvina BouleauFlore Renaud
Jul 19, 2003·European Journal of Biochemistry·Constantina ConstantinouMichael J Clemens
Oct 15, 2011·PLoS Pathogens·Jung Hwa KimJoanne N Engel
Aug 25, 2010·Pharmacology & Therapeutics·Gabriella LeonarduzziGiuseppe Poli
Apr 15, 2008·Cancer Letters·Masuko Ushio-Fukai, Yoshimasa Nakamura
Apr 15, 2006·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Vigdis SørensenAntoni Wiedłocha
Jul 8, 2014·Frontiers in Oncology·Brittany Anne DavidsonAngeles Alvarez Secord
Jul 5, 2016·Oncogene·A-S TournillonR Fåhraeus
Jun 18, 2017·Cell Death and Differentiation·Ignacio LópezRobin Fåhraeus
Aug 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shigetada Teshima-KondoAnne-Catherine Prats
Jan 21, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Irma G Gonzalez-HerreraAnne-Catherine Prats
Feb 14, 2020·Cancers·Leïla T S FuséeIgnacio López
Jul 26, 2011·Molecular Reproduction and Development·Marcin ChruscielAneta Andronowska
Aug 10, 2017·Wiley Interdisciplinary Reviews. RNA·Rajat RoyOlivier E Pardo
Apr 14, 2018·International Journal of Molecular Sciences·Peace Mabeta
Jun 9, 2018·Cancers·Virginie MarcelJean-Jacques Diaz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.